Group structure
6 companies in 3 countries
Canada1
Switzerland1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loadingโฆ
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1โ25 of 28
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BURINEX1 mg ยท Tablet | Bumetanide | Canada | Marketed | 1993 |
| BURINEX5 mg ยท Tablet | Bumetanide | Canada | Marketed | 1993 |
| Burinex 0,5 mg/ml, oplossing voor injectieOplossing voor injectie | Bumetanide | Netherlands | Authorised | 1988 |
| Burinex 1 mg, tablettenTablet | Bumetanide | Netherlands | Authorised | 1976 |
| Burinex 2 mg, tablettenTablet | Bumetanide | Netherlands | Authorised | 1995 |
| Burinex 5 mg, tablettenTablet | Bumetanide | Netherlands | Authorised | 1981 |
| Condyline 0,5%, applicatievloeistof 5 mg/mlVloeistof voor cutaan gebruik | Podophyllotoxin | Netherlands | Authorised | 1987 |
| FORDIURAN 1 mg COMPRIMIDOS1 mg ยท Comprimido | Bumetanide | Spain | Marketed | 1973 |
| LAMISIL1% ยท GEL | Terbinafine | United States | Not marketed | 1998 |
| LAMISIL1% ยท Solution | Terbinafine | United States | Not marketed | 1997 |
| Lamisil 10 mg/g kremakrema | Terbinafine | Croatia | Marketed | 2024 |
| LAMISIL AT1% ยท GEL | Terbinafine | United States | Marketed | 2006 |
| LAMISIL AT1% ยท Solution | Terbinafine | United States | Marketed | 2000 |
| LAMISIL AT1% ยท Spray | Terbinafine | United States | Marketed | 2000 |
| Lamisil DermGel 1%, gelGel | Terbinafine | Netherlands | Authorised | 2000 |
| Lamisil DermGel 10 mg/g gelgel | Terbinafine | Croatia | Not marketed | 2024 |
| Lamisil huidschimmelcrรจme 10 mg/g, hydrofiele crรจmeCrรจme | Terbinafine | Netherlands | Authorised | 1991 |
| Lamisil Lotion 1%, oplossing voor cutaan gebruikOplossing voor cutaan gebruik | Terbinafine | Netherlands | Authorised | 1998 |
| Lamisil once 1%, oplossing voor cutaan gebruik 10 mg/gOplossing voor cutaan gebruik | Terbinafine | Netherlands | Authorised | 2006 |
| Lamisil Once 10 mg/g otopina za koลพuotopina za koลพu | Terbinafine | Croatia | Authorised | 2024 |
| Lamisil Spray 1%, huidspray, oplossingHuidspray, oplossing | Terbinafine | Netherlands | Authorised | 1998 |
| Lamisil voetschimmelcrรจme 10 mg/g, hydrofiele crรจmeCrรจme | Terbinafine | Netherlands | Authorised | 2013 |
| SELEXID200 mg ยท Tablet | Pivmecillinam | Canada | Authorised | |
| SELEXID400 mg ยท Tablet | Pivmecillinam | Canada | Authorised | |
| SELEXID 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG400 mg ยท Comprimido recubierto con pelรญcula | Pivmecillinam | Spain | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 12 | 12 | 0 | CompaniesAll medicines |
| United States | 5 | 5 | 0 | CompaniesAll medicines |
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
| Spain | 3 | 3 | 0 | CompaniesAll medicines |
| Croatia | 3 | 3 | 0 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Colombia, France, Italy, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Federal Commercial Registry Office;exact dataset/law title,source URI/link and retrieval date;Prognia separately labelled normalization;no endorsement.
Licence: opendata.swiss terms_by
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep KAROโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.